Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Graft-versus-host disease	4/42	1.2961519981889268e-07	4.094283796981882e-06	140.87719298245614	-275.439099811649	IFNG;IL1A;IL1B;TNF
KEGG_2021_Human	Type I diabetes mellitus	4/43	1.4282385338308892e-07	4.094283796981882e-06	137.24786324786325	-270.484873589769	IFNG;IL1A;IL1B;TNF
KEGG_2021_Human	Hematopoietic cell lineage	5/99	5.996272195397143e-08	4.094283796981882e-06	84.82978723404256	-233.2293906932695	CSF3;FLT3;IL1A;IL1B;TNF
KEGG_2021_Human	Malaria	4/50	2.654180841966383e-07	5.706488810227724e-06	116.26086956521739	-240.55570695978312	CSF3;IFNG;IL1B;TNF
KEGG_2021_Human	Inflammatory bowel disease	4/65	7.733227471018954e-07	1.3301151250152602e-05	87.50819672131148	-195.3419859289311	IFNG;IL1A;IL1B;TNF
KEGG_2021_Human	Leishmaniasis	4/77	1.5346775084568718e-06	2.199704428788183e-05	73.01369863013699	-170.21630123625883	IFNG;IL1A;IL1B;TNF
KEGG_2021_Human	IL-17 signaling pathway	4/94	3.423271653145718e-06	3.680017027131647e-05	59.096296296296295	-144.19803777501954	CSF3;IFNG;IL1B;TNF
KEGG_2021_Human	Rheumatoid arthritis	4/93	3.2795638728842682e-06	3.680017027131647e-05	59.767790262172284	-145.5024915816698	IFNG;IL1A;IL1B;TNF
KEGG_2021_Human	Osteoclast differentiation	4/127	1.1374005182336485e-05	9.781644456809378e-05	43.06233062330623	-111.27061146114511	IFNG;IL1A;IL1B;TNF
KEGG_2021_Human	African trypanosomiasis	3/37	1.0384632752750053e-05	9.781644456809378e-05	101.26890756302521	-158.85054794063166	IFNG;IL1B;TNF
KEGG_2021_Human	Cytokine-cytokine receptor interaction	5/295	1.3609445164786277e-05	0.00010640111674287452	26.820689655172412	-87.5981964107033	CSF3;IFNG;IL1A;IL1B;TNF
KEGG_2021_Human	Fluid shear stress and atherosclerosis	4/139	1.6271599911932136e-05	0.00011661313270218032	39.175308641975306	-102.69295126036515	IFNG;IL1A;IL1B;TNF
KEGG_2021_Human	Necroptosis	4/159	2.7677777198301538e-05	0.0001830991414656871	34.034408602150535	-90.91492941118791	IFNG;IL1A;IL1B;TNF
KEGG_2021_Human	Influenza A	4/172	3.7714889820243616e-05	0.00023167718032435363	31.349206349206348	-84.54495262531024	IFNG;IL1A;IL1B;TNF
KEGG_2021_Human	Tuberculosis	4/180	4.508970382755845e-05	0.00025851430194466843	29.893939393939394	-81.02434645013932	IFNG;IL1A;IL1B;TNF
KEGG_2021_Human	Pertussis	3/76	9.159620399517935e-05	0.000492329596474089	46.93737769080235	-88.55605413655218	IL1A;IL1B;TNF
KEGG_2021_Human	Chagas disease	3/102	0.00021994493140062025	0.0009955402158133338	34.497835497835496	-68.58379435140506	IFNG;IL1B;TNF
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	3/100	0.00020740615092509237	0.0009955402158133338	35.2179675994109	-69.8003308229761	IL1A;IL1B;TNF
KEGG_2021_Human	Amoebiasis	3/102	0.00021994493140062025	0.0009955402158133338	34.497835497835496	-68.58379435140506	IFNG;IL1B;TNF
KEGG_2021_Human	MAPK signaling pathway	4/294	0.0003034351122757725	0.001304770982785822	17.880459770114943	-49.762697732575255	FLT3;IL1A;IL1B;TNF
KEGG_2021_Human	Yersinia infection	3/137	0.0005248515914701949	0.0021493922317350838	25.375266524520256	-52.38188378130509	IL1B;MEFV;TNF
KEGG_2021_Human	Non-alcoholic fatty liver disease	3/155	0.0007531180482518497	0.002944006915893594	22.31954887218045	-46.57552582678881	IL1A;IL1B;TNF
KEGG_2021_Human	Allograft rejection	2/38	0.0009469209383415865	0.0035406608998859324	55.77777777777778	-62.87407127134141	IFNG;TNF
KEGG_2021_Human	NOD-like receptor signaling pathway	3/181	0.0011822602400977265	0.004236432527016853	18.996789727126806	-40.00053498134924	IL1B;MEFV;TNF
KEGG_2021_Human	Legionellosis	2/57	0.0021229405609363423	0.007302915529621017	36.42272727272727	-44.890022889750604	IL1B;TNF
KEGG_2021_Human	Coronavirus disease	3/232	0.0024164136009215383	0.007992752679971243	14.670617592014972	-30.966105875434415	CSF3;IL1B;TNF
KEGG_2021_Human	Acute myeloid leukemia	2/67	0.002921615714870147	0.009305887091808615	30.78076923076923	-39.02900444511024	FLT3;MPO
KEGG_2021_Human	Antigen processing and presentation	2/78	0.003939415117888246	0.011682403453047902	26.289473684210527	-34.099339569929285	IFNG;TNF
KEGG_2021_Human	Prion disease	3/273	0.0038397781028777236	0.011682403453047902	12.377777777777778	-25.926933584065353	IL1A;IL1B;TNF
KEGG_2021_Human	TGF-beta signaling pathway	2/94	0.005673660825135872	0.016264494365389497	21.67391304347826	-28.742216935482162	IFNG;TNF
KEGG_2021_Human	Toll-like receptor signaling pathway	2/104	0.006906399428166279	0.017469127965361767	19.524509803921568	-26.130280011490946	IL1B;TNF
KEGG_2021_Human	T cell receptor signaling pathway	2/104	0.006906399428166279	0.017469127965361767	19.524509803921568	-26.130280011490946	IFNG;TNF
KEGG_2021_Human	NF-kappa B signaling pathway	2/104	0.006906399428166279	0.017469127965361767	19.524509803921568	-26.130280011490946	IL1B;TNF
KEGG_2021_Human	C-type lectin receptor signaling pathway	2/104	0.006906399428166279	0.017469127965361767	19.524509803921568	-26.130280011490946	IL1B;TNF
KEGG_2021_Human	Th17 cell differentiation	2/107	0.00729809140286639	0.017932453161328844	18.95952380952381	-25.42995427691617	IFNG;IL1B
KEGG_2021_Human	Toxoplasmosis	2/112	0.007973056255711614	0.018531968594356726	18.086363636363636	-24.33571316400054	IFNG;TNF
KEGG_2021_Human	TNF signaling pathway	2/112	0.007973056255711614	0.018531968594356726	18.086363636363636	-24.33571316400054	IL1B;TNF
KEGG_2021_Human	Alzheimer disease	3/369	0.008924054845697141	0.020196545177104057	9.018735362997658	-18.187178129854335	IL1A;IL1B;TNF
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	2/131	0.010785539693571716	0.023783497785824812	15.385658914728682	-20.853034219946885	IFNG;TNF
KEGG_2021_Human	Systemic lupus erythematosus	2/135	0.011426598240460687	0.02456718621699048	14.915413533834586	-20.230385574789178	IFNG;TNF
KEGG_2021_Human	Measles	2/139	0.012084353093672291	0.025347667464776024	14.472627737226277	-19.639406588988233	IL1A;IL1B
KEGG_2021_Human	Hepatitis C	2/157	0.015246968798416489	0.031219983730090908	12.762903225806452	-17.312716751580805	IFNG;TNF
KEGG_2021_Human	JAK-STAT signaling pathway	2/162	0.016183180370760934	0.03236636074152187	12.35625	-16.748364182562245	CSF3;IFNG
KEGG_2021_Human	Pathways of neurodegeneration	3/475	0.017772166326566263	0.034736506911015874	6.897094430992736	-13.07371705691191	IL1A;IL1B;TNF
KEGG_2021_Human	Herpes simplex virus 1 infection	3/498	0.020174850542549024	0.038556381036871465	6.556709956709956	-12.239051897711217	IFNG;IL1B;TNF
KEGG_2021_Human	Transcriptional misregulation in cancer	2/192	0.0223068963273402	0.04170419748154907	10.365789473684211	-13.920708621090329	FLT3;MPO
KEGG_2021_Human	Pathogenic Escherichia coli infection	2/197	0.0234094024256627	0.04283422571504239	10.093589743589744	-13.525208778126117	IL1B;TNF
KEGG_2021_Human	Terpenoid backbone biosynthesis	1/22	0.026917919418171	0.04822793895755637	42.576719576719576	-21.34946103825324	MVK
KEGG_2021_Human	Lipid and atherosclerosis	2/215	0.027564399546120597	0.048378333897272884	9.219483568075118	-12.240131856521	IL1B;TNF
KEGG_2021_Human	Human cytomegalovirus infection	2/225	0.029995320515188703	0.051591951286124565	8.794843049327355	-11.607417281005194	IL1B;TNF
KEGG_2021_Human	Shigellosis	2/246	0.035374463538784595	0.059651056163440686	8.01639344262295	-10.432967830507518	IL1B;TNF
KEGG_2021_Human	Salmonella infection	2/249	0.03617242514905692	0.05982362620805568	7.915991902834008	-10.280113155611538	IL1B;TNF
KEGG_2021_Human	Asthma	1/31	0.03774052193970927	0.06123933748707542	29.77037037037037	-16.126223630092912	TNF
KEGG_2021_Human	Type II diabetes mellitus	1/46	0.05553766478796506	0.086840712213909	19.809876543209878	-11.46289716991079	TNF
KEGG_2021_Human	Proteasome	1/46	0.05553766478796506	0.086840712213909	19.809876543209878	-11.46289716991079	IFNG
KEGG_2021_Human	PI3K-Akt signaling pathway	2/354	0.06828569708469599	0.10486732052292598	5.480113636363637	-6.479364551821025	CSF3;FLT3
KEGG_2021_Human	Cytosolic DNA-sensing pathway	1/63	0.0753492056247738	0.11368476638123767	14.347670250896057	-8.574814690072902	IL1B
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.11757693900198633	13.071895424836601	-7.854937277937848	TNF
KEGG_2021_Human	Central carbon metabolism in cancer	1/70	0.08339759626885078	0.11757693900198633	12.880837359098228	-7.74542097629872	FLT3
KEGG_2021_Human	RIG-I-like receptor signaling pathway	1/70	0.08339759626885078	0.11757693900198633	12.880837359098228	-7.74542097629872	TNF
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.11757693900198633	13.26865671641791	-7.96724592924887	TNF
KEGG_2021_Human	Peroxisome	1/82	0.09704826642438931	0.13461533729834646	10.956104252400548	-6.615247747466243	MVK
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.14250035818469858	9.961298377028713	-6.010407578745034	TNF
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/89	0.10492639565254669	0.14250035818469858	10.075757575757576	-6.080768259179883	IFNG
KEGG_2021_Human	Th1 and Th2 cell differentiation	1/92	0.10828375753966943	0.1432677407447934	9.739926739926739	-5.8737398650795125	IFNG
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.14690703569139588	9.32514619883041	-5.615549699272252	TNF
KEGG_2021_Human	Inflammatory mediator regulation of TRP channels	1/98	0.11496450084552494	0.147566374219629	9.130584192439862	-5.49346810373269	IL1B
KEGG_2021_Human	Viral protein interaction with cytokine and cytokine receptor	1/100	0.11718138394436346	0.14819998557669498	8.94388327721661	-5.375723879218761	TNF
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.15394683250282454	8.2668743509865	-4.943743954376122	TNF
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.15394683250282454	8.189300411522634	-4.893732148578802	IFNG
KEGG_2021_Human	Drug metabolism	1/108	0.12599902727061665	0.15394683250282454	8.2668743509865	-4.943743954376122	MPO
KEGG_2021_Human	Pathways in cancer	2/531	0.13679480156092927	0.16256811357682324	3.5628544423440456	-3.410136075895621	FLT3;IFNG
KEGG_2021_Human	Sphingolipid signaling pathway	1/119	0.13799386385009413	0.16256811357682324	7.4858757062146895	-4.435243302362896	TNF
KEGG_2021_Human	Apoptosis	1/142	0.16259648475288416	0.1889634822803789	6.2466509062253746	-3.6047270952512624	TNF
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.1979795454772963	5.74800290486565	-3.2620286219941206	TNF
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.1979795454772963	5.672401433691756	-3.209640069203435	IL1A
KEGG_2021_Human	Phagosome	1/152	0.17309473207732412	0.1979795454772963	5.82560706401766	-3.3156870475343334	MPO
KEGG_2021_Human	Hepatitis B	1/162	0.18347437883820783	0.2022922638472548	5.456866804692892	-3.0596637281364782	TNF
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.22960509926301995	4.657210401891253	-2.4954112144854435	MPO
KEGG_2021_Human	Epstein-Barr virus infection	1/202	0.22383065271253133	0.2406179516659712	4.3488114980652295	-2.274707784911856	TNF
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.24078273123225846	4.283224400871459	-2.2275706216550177	TNF
KEGG_2021_Human	Human immunodeficiency virus 1 infection	1/212	0.23363497492364255	0.24503180296869828	4.137440758293839	-2.12256354972075	TNF
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.24043153000367978	0.24912182626887303	4.001019367991845	-2.0240281738454993	TNF
KEGG_2021_Human	Ras signaling pathway	1/232	0.25290994493508406	0.2589316102906813	3.7696007696007694	-1.8563524399324505	FLT3
KEGG_2021_Human	Human papillomavirus infection	1/331	0.3420488957114324	0.346073000366861	2.6053872053872054	-1.0106876845884132	TNF
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.3695602254440061	2.3584328129782675	-0.8341701676241932	TNF
